Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Aliskiren is a novel renin inhibitor approved for the treatment of hypertension. The effect
of aliskiren on arterial stiffness, inflammation and oxidative stress has not been fully
investigated yet.The aim of this study is to investigate the effect of aliskiren on arterial
stiffness, platelet function and inflammation compared to losatan in patients with diabetes
mellitus.
We hypothesize that aliskiren will have a beneficial effect on arterial stiffness and
platelet function in patients with diabetes mellitus.